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Dear Editor, 
 
Ursolic acid (3-beta-3-hydroxy-urs-12-ene-28-oic-acid; UA) is a lipophilic pentacyclic 
triterpenoid; it was found to be present in the epicuticular waxes of apples in 1920. It is wide-
ly found naturally in the peels of fruits, as well as in many herbs and spices such as lavender, 
oregano, thyme, rosemary, and thyme (Woźniak et al., 2015). UA has been confirmed to have 
several biological and pharmacological effects, such as anti-inflammatory (Baricevic et al., 
2001), antitumor (Baglin et al., 2003), antiplatelet aggregation (Babalola et al., 2013), anti-
HIV (Kashiwada et al., 2000), and anti-Mycobacterium tuberculosis effects (Cantrell et al., 
2001). 
Its many pharmaceutical and biological properties make it an interesting material for ap-
plication in the pharmaceutical, food, and cosmetics industries. Herein, we review the most 
recent studies on UA and its biological and pharmacological activities (Table 1).  
 
 
Table 1: Recent studies on ursolic acid and its biological and pharmacological activities 
Key message Reference 
Ursolic acid (UA) not only inhibits cell growth but also induces apoptosis 
through modulation of the phosphatidylinositol-3-kinase (PI3K)/Akt/mTOR 
pathway in human prostate cancer cells. This finding suggests that UA may be 
a new chemotherapeutic candidate against prostate cancer. 
Meng et al., 2015 
The antifibrotic effect of UA is partially due to its oxidative stress attenuating 
effect through manipulation of NADPH oxidase 4 activity and expression. This 
result suggests that UA may be a promising antifibrotic agent. 
He et al., 2015 
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Table 1 (cont.): Recent studies on ursolic acid and its biological and pharmacological activities 
Key message Reference 
A multi-inlet vortex mixer is a robust and pragmatic tool for tailoring the particle 
size of a UA nanosuspension. Particle size appears to be a critical determinant 
of the anticancer activity of the UA nanoparticles. 
Wang et al., 2015 
UA, which is reported to have antitumor activity, might be useful in sensitizing 
tumor cells to radiation therapy by inhibiting pathways leading to radiation 
therapy resistance. 
Yang et al., 2015 
UA increases free fatty acid (FFA) burning by enhancing skeletal muscle FFA 
uptake and ncing skele via uncoupling protein 3/AMP-activated protein kinase-
dependent pathway, which provides a novel perspective on the biological func-
tion of UA against obesity and IR. 
Chu et al., 2015 
UA from Prunella vulgaris enhances sleep duration through GABAA receptor 
activation and could be a therapeutic candidate for insomnia treatment. Jeon et al., 2015 
The greater ability of the combination of UA and resveratrol to inhibit skin tu-
mor progression was attributable to the greater inhibitory effects on growth 
factor and inflammatory signaling, skin inflammation, and epidermal hyperpro-
liferation induced by 12-O-tetracanoylphorbol-13-acetate (TPA) treatment. 
Cho et al., 2015 
The combination of UA and artesunate can reduce both triglyceride and cho-
lesterol, and the effects were more potent than of either agent alone, which 
indicates a strong synergistic effect. 
Yuliang et al., 2015 
UA might be considered as a potential candidate for treatment of pathological 
conditions associated with muscular atrophy and dysfunction, including skele-
tal muscle atrophy, amyotrophic lateral sclerosis, sarcopenia, and metabolic 
diseases of the muscles. 
Bakhtiari et al., 2015
UA in concentrations of l x 107 mol/L to 5 x 105 mol/L induced relaxation of 
gastric smooth muscle (SM) tissues in a concentration-dependent manner. 
Prissadova et al., 
2015 
UA and oleanolic acid extracted from wild loquat leaves can significantly inhibit 
the viability of A549 cells (human lung adenocarcinoma epithelial cell line). Yuan et al., 2015 
The beneficial effects of UA on nonalcoholic fatty liver disease (NAFLD) may 
be due to its ability to increase lipid heoxidation and to inhibit hepatic endo-
plasmic reticulum stress. Together, UA may be further considered as a natural 
compound for NAFLD treatment. 
Li et al., 2015 
UA ameliorated the symptoms of experimental autoimmune myasthenia gravis 
(EAMG), a rat model of MG. These findings suggest a new strategy to treat 
EAMG and even human MG. 
Xu et al., 2015 
UA and its novel prodrug derivative US597 modulate expression of cell adhe-
sion molecules within the focal adhesion signaling pathway, leading to cancer 
cell motility. 
Xiang et al., 2015 
UA protects against wear particle-induced osteolysis by suppressing osteo-
clast formation and function. Jiang et al., 2015 
Folic acid-modified dendrimeric UA prodrugs have the potential for targeted 
delivery of UA into cancer cells to improve its anti-tumor efficacy. Gao et al., 2015 
UA induces apoptosis and inhibits the invasive phenotype of gastric cancer 
cells; therefore, it may have potential application as a chemopreventive agent 
to prevent the metastasis of gastric cancer or to alleviate metastasis. 
Kim and Moon, 2015
A potential novel mechanism by which UA controls the growth of hepatocellu-
lar carcinoma (HCC) cells and suggests that DNA methyltransferase 1 could 
be a novel target for HCC chemoprevention and treatment. 
Yie et al., 2015 
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Table 1 (cont.): Recent studies on ursolic acid and its biological and pharmacological activities 
Key message Reference 
The combination of UA and leucine promotes muscle cell differentiation, thus 
suggesting that this combination of agents may prove to be beneficial in in-
creasing muscle mass. 
Kim et al., 2015 
UA-induced mitochondrial reactive oxygen species (ROS) production can elicit 
mitochondrial uncoupling and glutathione-dependent antioxidant responses, 
which offer cytoprotection against oxidant injury in H9c2 cells. 
Chen et al., 2015 
UA significantly prevented carbon tetrachloride-induced hepatotoxicity and 
fibrosis, indicated by both diagnostic indicators and histopathological analysis. Ma et al., 2015 
UA exerts protective effects in cecal ligation and puncture-induced septic rats, 
and may be a potential therapeutic agent against sepsis. Hu et al., 2015 
UA ameliorates lipid and glucose metabolism in high-fat diet-fed mice, primari-
ly by the activation of peroxisome proliferation-activated receptor-α and induc-
tion of the hepatic autophagy pathway. Thus, intake of UA in the diet or in an 
isolated form may ameliorate lipid and glucose metabolism. 
Jia et al., 2015 
UA activated the phagocytosis of human monocytes through MRP8 induction. 
These data suggest that UA firmly contributes to the intracellular killing effect 
of macrophages during mycobacterial infection. 
Podder et al., 2015 
UA may attenuate early brain injury after subarachnoid hemorrhage in rats by 
suppressing the toll-like receptor 4-mediated inflammatory pathway. Zhang et al., 2014 
UA and xylitol, synergistic inhibitors, could be potential agents for enhancing 
the antimicrobial and anti-biofilm efficacy against S. mutans and S. sobrinus in 
the oral environment. 
Zou et al., 2014 
UA exhibits significant anti-tumor effects by suppressing cell proliferation, 
promoting apoptosis, and inducing cell cycle arrest both in vitro and in vivo. It 
may be a potential agent for treating gallbladder cancer. 
Weng et al., 2014 
In vitro, in silico, and in vivo results indicate that UA is a promising, inexpen-
sive, widely available natural lead, which can be designed and developed into 
a macrofilaricidal drug. This is the first ever report on the anti-filarial potential 
of UA from E. tereticornis.  
Kalani et al., 2014 
UA, a bioactive natural compound, inhibits superoxide anion generation and 
elastase release in human neutrophils and ameliorates trauma- and hemor-
rhagic shock-induced organ injury in rats. 
Hwang et al., 2014 
UA-induced elevation of serum irisin may be useful as a strategy for the en-
hancement of skeletal muscle strength during resistance training in men. Bang et al., 2014 
UA stimulates glucose uptake in 3T3-L1 adipocytes through the PI3K pathway, 
providing important information regarding the anti-diabetic mechanism of ac-
tion of UA. 
He et al., 2014 
The antihyperglycemic role of UA is mediated through insulin secretion and 
insulinomimetic effect on glucose uptake, synthesis, and translocation of 
GLUT4 by a mechanism of cross-talk between calcium and protein kinases. 
UA is a potential anti-diabetic agent with pharmacological properties for insulin 
resistance and diabetes therapy. 
Castro et al., 2015 
UA can increase serum S100 protein expression and promote neural regener-
ation in BALB/c mice following sciatic nerve injury, in a dose-dependent man-
ner. 
Liu et al., 2013 
 
EXCLI Journal 2016;15:221-228 – ISSN 1611-2156 
Received: January 21, 2016, accepted: February 17, 2016, published: March 14, 2016 
 
 
224 
Table 1 (cont.): Recent studies on ursolic acid and its biological and pharmacological activities 
Key message Reference 
Combination treatment with UA and rosiglitazone down-regulated lipogenic 
genes and upregulated fatty acid oxidative genes in high-fat diet-fed mice. This 
study suggests that UA in combination with rosiglitazone reduced lipid accu-
mulation in liver. 
Sundaresan et al., 
2014 
UA treatment significantly ameliorates collagen-induced arthritis in mice via 
suppression of Th17 and differentiation. By targeting pathogenic Th17 cells 
and autoantibody production, UA may be useful for the treatment of autoim-
mune arthritis and other Th17-related diseases. 
Baek et al., 2014 
Low-dose UA had preventive potency for diabetic renal complications, which 
could be mediated by changes in hepatic glucose metabolism and the renal 
polyol pathway. High-dose UA was more effective anti-dyslipidemia therapy in 
non-obese type 2 diabetic mice. 
Lee et al., 2014 
UA exerts its antifilarial effect through induction of apoptosis and by downregu-
lating and altering the level of some key antioxidants such as GSH, GST, and 
SOD of Setaria cervi.  
Saini et al., 2014 
UA inhibits nuclear factor-kappa B activation in both intestinal epithelial cells 
and macrophages, and attenuates experimental murine colitis. These results 
suggest that UA is a potential therapeutic agent for inflammatory bowel dis-
ease. 
Chun et al., 2014 
UA could be useful as an adjunct therapy for the treatment of infections involv-
ing methicillin-resistant Staphylococcus aureus biofilms. Ou et al., 2014 
The apoptotic mechanism of UA treatment in HeLa cells involved the mito-
chondrial intrinsic pathway and was closely associated with the suppression of 
the ERK1/2 signaling pathway. 
Li et al., 2014 
The inhibition of carbon tetrachloride-induced inflammation by UA is due at 
least in part to its antioxidant activity and its ability to modulate the S phos-
phorylation of transcription 3 (TAT3) and nuclear factor-kappa B signaling 
pathways. 
Ma et al., 2014 
UA as a direct negative regulator of the mechanistic target of rapamycin com-
plex 1 signaling pathway and this suggests a novel mechanism by which UA 
exerts its beneficial function. 
Qu et al., 2013 
H2O2 causes the malignant transformation of WB-F344 cells. UA exerts anti-
tumor effects by inhibiting the proliferation in malignantly transformed WB-
F344 cells.  
Han et al., 2014 
UA exerts anticancer activity against colon cancer cells by promoting the N-
terminal phosphorylation and subsequent proteasomal degradation of ainst 
colo. 
Kim et al., 2014 
UA could induce the differentiation of the human leukemia cell line U937 by 
activating the PI3K/Akt pathway, and it could be a potential candidate as a dif-
ferentiation-inducing agent for leukemia therapy. 
Deng et al., 2014 
UA treatment exhibited a protective effect on kidneys in diabetic rats, implying 
that it could be a potential treatment for diabetic nephropathy. Ling et al., 2013 
UA and its derivatives were examined for their radical scavenging activity by 
using the DPPH assay, and showed significant antioxidant activity. 
do Nascimento et 
al., 2014 
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Table 1 (cont.): Recent studies on ursolic acid and its biological and pharmacological activities 
Key message Reference 
Signal transducer and activator of transcription 3 (STAT3) is a target for colon 
cancer prevention. UA, a dietary agent, might offer an effective approach for 
colorectal carcinoma prevention by inhibiting the persistently activated STAT3 
in cancer stem cells. 
Wang et al., 2013 
UA induces the activation of p53, NF-e , and Bax, leading to the enhancement 
of p21 transcriptional activity and activation of caspase-9 and -3, thus finally 
inducing apoptosis of human colon adenocarcinoma cells, SW480 cells. 
Nam and Kim et al., 
2013 
The inhibition of tumor angiogenesis via suppression of multiple signaling 
pathways might be one of the mechanisms whereby UA can be effective in 
cancer treatment. 
Lin et al., 2013 
UA nanocrystals may be used as a potential delivery formulation for intrave-
nous injection with enhanced dissolution velocity and anticancer activity. Song et al., 2014 
UA inhibits the growth of cariogenic microorganisms, which suggests that it 
has considerable potential as an antibacterial agent for dental caries preven-
tion. 
Zhou et al., 2013 
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